The Enterprise Value as of December 2025 (TTM) for Abbisko Cayman Limited (2256.HK) is 7.32B

According to Abbisko Cayman Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 7.32B. This represents a change of 108.89% compared to the average of 3.50B of the last 4 quarters.

Abbisko Cayman Limited (2256.HK) Historical Enterprise Value (quarterly & annually)

How has 2256.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Abbisko Cayman Limited over the last ten years is 2.89B. The current 7.32B Enterprise Value has changed 25.24% with respect to the historical average. Over the past ten years (40 quarters), 2256.HK's Enterprise Value was at its highest in in the June 2021 quarter at 8.62B. The Enterprise Value was at its lowest in in the September 2022 quarter at -703770502.93.

Abbisko Cayman Limited (2256.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Abbisko Cayman Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Abbisko Cayman Limited (2256.HK) Average Enterprise Value

How has 2256.HK Enterprise Value performed in the past?

The current Enterprise Value of Abbisko Cayman Limited (2256.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Abbisko Cayman Limited (2256.HK) Enterprise Value vs. Peers

How is 2256.HK’s Enterprise Value compared to its peers?

Abbisko Cayman Limited’s Enterprise Value is greater than CARsgen Therapeutics Holdings Limited (6.40B), less than Alphamab Oncology (9.02B), greater than HBM Holdings Limited (1.09B), less than Ascletis Pharma Inc. (9.76B), less than CStone Pharmaceuticals (7.89B), less than Nanjing Leads Biolabs Co Ltd (0), less than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (10.31B), greater than IVD Medical Holding Limited (5.33B), less than CK Life Sciences Int'l., (Holdings) Inc. (13.68B), less than Lepu Biopharma Co., Ltd. (9.31B),

Build a custom stock screener for Abbisko Cayman Limited (2256.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abbisko Cayman Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abbisko Cayman Limited (2256.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abbisko Cayman Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.